Researchers have revealed an innovative nuclear medicine test which could improve the care of patients with type 1 diabetes mellitus . According to current research, the novel positron emission tomography (PET) imaging method could quantify beta-cell mass , which would greatly improve the monitoring of the diabetic condition and hence, guide diabetes therapies.